Literature DB >> 28818001

Pulmonary drug delivery system: newer patents.

Shahid Sukhbir Kaur1.   

Abstract

Inhalational route for drug delivery and desired effects has been known since centuries. This lung-targeted therapy has benefited asthmatics and those with chronic respiratory problems. The technique has evolved greatly from crude pots and pipes to modern sophisticated drug-dispensing devices. This mode is effective, rapid and safe. Its outcome, however, is majorly determined by drug formulation, device structure and patient's coordinating skill. In spite of great advances in this field, more efforts are required to meet the unmet needs. This noninvasive mode is being increasingly studied for transfer of drugs for systemic action with promising results. The present article is an attempt to capture the recent development and progress in this field and review relevant newer patents.

Entities:  

Keywords:  drug administration; drug delivery; dry powder inhaler; formulations; lungs; metered-dose inhaler; nanotechnology; nebulizer; newer patents; pulmonary

Mesh:

Year:  2017        PMID: 28818001     DOI: 10.4155/ppa-2017-0019

Source DB:  PubMed          Journal:  Pharm Pat Anal        ISSN: 2046-8954


  2 in total

Review 1.  The future of inhalation therapy in chronic obstructive pulmonary disease.

Authors:  Mario Cazzola; Josuel Ora; Luigino Calzetta; Paola Rogliani; Maria Gabriella Matera
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-02-17

2.  Aerosol Characteristics and Physico-Chemical Compatibility of Combivent® (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine.

Authors:  Rui Zhang; Junhua Hu; Liangjun Deng; Sha Li; Xi Chen; Fei Liu; Shanping Wang; Khaja Shameem Mohammed Abdul; Huimin Beng; Wen Tan
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.